Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

adverse events

  • You have access
    Adverse Events and Economic Burden Among Patients Receiving Systemic Treatment for Mantle Cell Lymphoma: A Real-World Retrospective Cohort Study
    SHAUM M. KABADI, STACEY DACOSTA BYFIELD, LISA LE and TEMITOPE OLUFADE
    Anticancer Research February 2021, 41 (2) 927-936; DOI: https://doi.org/10.21873/anticanres.14846
  • You have access
    Relationship Between Renal Function and the Incidence of Adverse Events in Patients With Colorectal Cancer Receiving Oxaliplatin
    DAICHI WATANABE, HIRONORI FUJII, YUNAMI YAMADA, HIROTOSHI IIHARA, TAKUMA ISHIHARA, NOBUHISA MATSUHASHI, TAKAO TAKAHASHI, KAZUHIRO YOSHIDA and AKIO SUZUKI
    Anticancer Research January 2020, 40 (1) 299-304; DOI: https://doi.org/10.21873/anticanres.13953
  • You have access
    Usefulness of Implementing Comprehensive Pharmaceutical Care for Metastatic Renal Cell Carcinoma Outpatients Treated with Pazopanib
    MAKI TODO, SUGURU SHIROTAKE, KOSHIRO NISHIMOTO, YOTA YASUMIZU, GOU KANEKO, HIDEYUKI KONDO, TAKASHI OKABE, HIDEKI MAKABE and MASAFUMI OYAMA
    Anticancer Research February 2019, 39 (2) 999-1004; DOI: https://doi.org/10.21873/anticanres.13205
  • You have access
    Efficacy and Toxicity of Induction Therapy with Cladribine, Idarubicin, and Cytarabine (IAC) for Acute Myeloid Leukemia
    SUSAN K. WOELICH, JAMES T. BRAUN, MARTIN W. SCHOEN, RESHMA RAMLAL, CARL E. FRETER, PAUL J. PETRUSKA and JACK M. LIONBERGER
    Anticancer Research February 2017, 37 (2) 713-717;
  • You have access
    Reduced Dose of Salvage-line Regorafenib Monotherapy for Metastatic Colorectal Cancer in Japan
    GEN HIRANO, AKITAKA MAKIYAMA, CHINATSU MAKIYAMA, TAITO ESAKI, HISANOBU ODA, KEITA UCHINO, MASATO KOMODA, RISA TANAKA, YUZO MATSUSHITA, KENJI MITSUGI, YOSHIHIRO SHIBATA, HOZUMI KUMAGAI, SHUJI ARITA, HIROSHI ARIYAMA, HITOSHI KUSABA, KOICHI AKASHI and EISHI BABA
    Anticancer Research January 2015, 35 (1) 371-377;
  • You have access
    Prospective Evaluation of Safety of Immune-cell Therapy for Patients with Various Types of Advanced Cancer
    TAKASHI KAMIGAKI, ERIKO MATSUDA, SACHIKO OKADA, KEIKO NAITOH, TAKASHIGE KONDO, HIROSHI IBE, RYUJI MAEKAWA and SHIGENORI GOTO
    Anticancer Research August 2014, 34 (8) 4601-4607;
  • You have access
    Analysis of Adverse Events of Bevacizumab-containing Systemic Chemotherapy for Metastatic Colorectal Cancer in Japan
    TAICHI ISOBE, KEITA UCHINO, CHINATSU MAKIYAMA, HIROSHI ARIYAMA, SHUJI ARITA, SHINGO TAMURA, MASATO KOMODA, HITOSHI KUSABA, TSUYOSHI SHIRAKAWA, TAITO ESAKI, KENJI MITSUGI, SHIGEO TAKAISHI, KOICHI AKASHI and EISHI BABA
    Anticancer Research April 2014, 34 (4) 2035-2040;
  • You have access
    Management of Adverse Events in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib and Clinical Outcomes
    MAKI ARAKAWA-TODO, TAKAHIKO YOSHIZAWA, KENJI ZENNAMI, GENYA NISHIKAWA, YOSHIHARU KATO, IKUO KOBAYASHI, KEISHI KAJIKAWA, YOSHIAKI YAMADA, KATSUHIKO MATSUURA, IKUTO TSUKIYAMA, HIROKO SAITO, TAKAAKI HASEGAWA, KOGENTA NAKAMURA and MAKOTO SUMITOMO
    Anticancer Research November 2013, 33 (11) 5043-5050;
  • You have access
    Clinical Significance of Erlotinib Monotherapy for Gefitinib-resistant Non-small Cell Lung Cancer with EGFR Mutations
    NOBUYUKI KOYAMA and YOSHITAKA UCHIDA
    Anticancer Research November 2013, 33 (11) 5083-5089;
Anticancer Research

© 2021 Anticancer Research

Powered by HighWire